Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model

Apoptosis

Volumn 13, Issue 1, 2008, Pages 77-86

  Hochhauser, Edith ^a,b   Pappo, Orit ^a,b   Ribakovsky, Evgeni ^a,b   Ravid, Amiram ^b   Kurtzwald, Efrat ^a,b   Cheporko, Yelena ^a,b   Lelchuk, Shlomo ^a,b   Ben Ari, Ziv ^b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Liver Institute   (Israel)

Author keywords

Apoptosis; Caspase 3; Erythropoietin; Ischemia reperfusion; Isolated; Liver; Mouse; Von Willebrand factor

Indexed keywords

CASPASE 3; I KAPPA B; LIVER ENZYME; RECOMBINANT ERYTHROPOIETIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENDOTHELIUM CELL; ENZYME ACTIVITY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOLATED LIVER; LIVER INJURY; LIVER ISCHEMIA; MALE; MOUSE; MULTIPLE DRUG DOSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SINGLE DRUG DOSE;

ANIMALS; APOPTOSIS; CASPASE 3; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; HUMANS; ISCHEMIA; LIVER; MALE; MAP KINASE KINASE 4; MICE; PROTEIN-SERINE-THREONINE KINASES; RANDOM ALLOCATION; REPERFUSION; REPERFUSION INJURY; VON WILLEBRAND FACTOR;

EID: 38049115939     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0155-8     Document Type: Article

References (36)

1. Clavien PA, Harvey PR, Strasberg SM (1992) Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 53:957-978
2. Jaeschke H (1996) Preservation injury: mechanisms, prevention and consequences. J Hepatol 25:774-780
3. Jaeschke H, Lemasters JJ (2003) Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125:1246-1257
4. Rudiger HA, Graf R, Clavien PA (2003) Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 16:149-159
5. Georgiev P, Dahm F, Graf R, Clavien PA (2006) Blocking the path to death: anti-apoptotic molecules in ischemica/reperfusion injury of the liver. Curr Pharm Des 12(23):2911-2921
6. Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, Brenner DA (2005) JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42:850-859
7. Lewis LD (2004) Preclinical and clinical studies: A preview of potential future applications of erythropoietic agents. Semin Hematol 41(suppl 7):217-225
8. Liu X, Xie W, Liu P, Duan M, Jia Z, Li W, Xu J (2006) Mechanism of cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion. Life Sci 78:2255-2264
9. Bogoyevitch MA (2004) An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cradiovasc Res 63:208-216
10. Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW et al (2003) Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 17(12):1754-1755
11. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P et al (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci 100(8):4802-4806
12. Chong ZZ, Kang JQ, Maiese K (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22(5):503-514
13. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95(8):4635-4640
14. Weinbroum A, Nielsen VG, Tan S, Gelman S, Matalon S, Skinner KA et al (1995) Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase. Am J Physiol 266:G998-G996
15. 3 increases the cellular content of the calcium-activated neutral protease mu-calpain in renal cell carcinoma. Endocrinology 135:2822-2825
16. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98(7):4044-4049
17. Sepodes B, Maio R, Pinto R, Sharples E, Oliveira P, McDonald M et al (2006) Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat. Transpl Int 19(11):919-926
18. Schmeding M, Neumann UP, Boas-Knoop S, Spinelli A, Neuhaus P (2007) Erythropoietin reduces ischemia-reperfusion injury in the rat liver. Eur Surg Res 39(3):189-197
19. Bendinelli P, Piccoletti R, Maroni P, Bernelli-Zazzera A (1996) The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett 398:193-197
20. Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G et al (1997) Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25:1128-1135
21. Crenesse D, Gugenheim J, Hornoy J, Tornieri K, Laurens M, Cambien B et al (2000) Protein kinase activation by warm and cold hypoxia-reoxygenation in primary-cultured rat hepatocytes JNK(1)/SAPK(1) involvement in apoptosis. Hepatology 32:1029-1036
22. Fan C, Yang J, Engelhardt JF (2002) Temporal pattern of NfkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion. J Cell Sci 115:4843-4853
23. Luedde T, Assmus U, Wustefeld T et al (2005) Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 115:849-859
24. Fan C, Li Q, Zhang Y et al (2004) IkappaB alpha and Ikappa B beta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J Clin Invest 113:746-755
25. Luedde T, Trautwein C (2006) Intracellular survival pathways in the liver. Liver Int 26(10):1163-1174
26. Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, Guiba-Tziampiri O, Tsakiris D (2006) Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 21(2):330-336
27. Natori S, Selzner M, Valentino KL, Fritz LC, Srinivasan A, Clavien PA, Gores GJ (1999) Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 68(1):89-96
28. Huet PM, Nagaoka MR, Desbiens G, Tarrab E, Brault A, Bralet MP, Bilodeau M (2004) Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology 39(4):1110-1119
29. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87(15):5978-5982
30. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91(9):3974-3978
31. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N (2003) Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 299(5608):890-893
32. Terayama N, Terada T, Nakanuma Y (1996) An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue. Histopathology 29:37-43
33. Urashima S, Tsutsumi M, Nakase K, Wang JS, Takada A (1993) Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Suppl 1B:77-84
34. Hattori M, Fukuda Y, Imoto M, Koyama Y, Nakano I, Urano F (1991) Histochemical properties of vascular and sinusoidal endothelial cells in liver diseases. Gastroenterol Jpn 26:336-343
35. Baruch Y, Neubauer K, Shenkar L, Sabo E, Ritzel A, Wilfling T, Ramadori G (2002) von Willebrand factor in plasma and in liver tissue after partial hepatectomy in the rat. J Hepatol 37(4):471-477
36. Moon C, Krawczyk M, Lakatta EG, Talan MI (2006) Therapeutic effectiveness of a single vs multiple doses of erythropoietin after experimental myocardial infarction in rats. Cardiovasc Drugs Ther 20(4):245-251